Covishield shows encouraging immune response in small Bangladesh study
UNB
14th May, 2021 09:51:27
The Oxford- AstraZeneca vaccine produced a strong immune response among vaccine recipients enrolled in a study by scientists at the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDRB) and the Institute of Epidemiology, Disease Control and Research (IEDCR).
Both the institutions said their findings were encouraging , raising hopes of strong protection for the age groups most at risk from the virus.
The vaccine recipients were aged between 40-73 years and from Dhaka city, with or without a history of Covid-19.
The ICDDRB and IEDCR scientists measured the levels of Covid-19 IgG antibodies in the blood of 120 participants before vaccination and then at one and two months after receiving their first dose of the vaccine through the government s vaccination campaign